These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 8576907)
21. Interaction between peroxisome proliferator-activated receptor gamma and its agonists: docking study of oximes having 5-benzyl-2,4-thiazolidinedione. Iwata Y; Miyamoto S; Takamura M; Yanagisawa H; Kasuya A J Mol Graph Model; 2001; 19(6):536-42, 598-600. PubMed ID: 11552681 [TBL] [Abstract][Full Text] [Related]
22. Differential activity of rosiglitazone enantiomers at PPAR gamma. Parks DJ; Tomkinson NC; Villeneuve MS; Blanchard SG; Willson TM Bioorg Med Chem Lett; 1998 Dec; 8(24):3657-8. PubMed ID: 9934490 [TBL] [Abstract][Full Text] [Related]
30. [A trend of insulin sensitizer which is under development]. Kadowaki T Nihon Rinsho; 2001 Nov; 59(11):2186-90. PubMed ID: 11712405 [No Abstract] [Full Text] [Related]
31. Peroxisome proliferator-activated receptor (PPAR) gamma agonists for diabetes. Moller DE; Greene DA Adv Protein Chem; 2001; 56():181-212. PubMed ID: 11329854 [No Abstract] [Full Text] [Related]
32. (3-substituted benzyl)thiazolidine-2,4-diones as structurally new antihyperglycemic agents. Nomura M; Kinoshita S; Satoh H; Maeda T; Murakami K; Tsunoda M; Miyachi H; Awano K Bioorg Med Chem Lett; 1999 Feb; 9(4):533-8. PubMed ID: 10098657 [TBL] [Abstract][Full Text] [Related]
33. Discovery of ligands for the nuclear peroxisome proliferator-activated receptors. Willson TM; Lehmann JM; Kliewer SA Ann N Y Acad Sci; 1996 Dec; 804():276-83. PubMed ID: 8993550 [TBL] [Abstract][Full Text] [Related]
40. Therapeutic journey of 2,4-thiazolidinediones as a versatile scaffold: An insight into structure activity relationship. Naim MJ; Alam MJ; Ahmad S; Nawaz F; Shrivastava N; Sahu M; Alam O Eur J Med Chem; 2017 Mar; 129():218-250. PubMed ID: 28231521 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]